The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Paliperidone palmitate for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2012
|
| DOI | 10.1002/14651858.cd008296.pub2 |
| Pubmed ID | |
| Authors |
Abraham M Nussbaum, T S Stroup |
| Abstract |
Paliperidone palmitate, a long-acting, intramuscular formulation of paliperidone, is now available for clinical use. Paliperidone is an active metabolite of risperidone and it is also available in an oral formulation for daily use. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 18% |
| Japan | 2 | 18% |
| Canada | 1 | 9% |
| India | 1 | 9% |
| Australia | 1 | 9% |
| United States | 1 | 9% |
| China | 1 | 9% |
| Unknown | 2 | 18% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 91% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 284 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Ireland | 1 | <1% |
| Brazil | 1 | <1% |
| South Africa | 1 | <1% |
| Singapore | 1 | <1% |
| Unknown | 279 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 42 | 15% |
| Researcher | 34 | 12% |
| Student > Bachelor | 32 | 11% |
| Student > Ph. D. Student | 25 | 9% |
| Other | 18 | 6% |
| Other | 51 | 18% |
| Unknown | 82 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 31% |
| Psychology | 32 | 11% |
| Nursing and Health Professions | 21 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 4% |
| Social Sciences | 9 | 3% |
| Other | 30 | 11% |
| Unknown | 91 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2021.
All research outputs
#2,068,544
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,369
of 11,842 outputs
Outputs of similar age
#12,357
of 181,239 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 179 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 181,239 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.